Safety and Effectiveness of Regorafenib in Sorafenib Treated Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: An International Multicenter Study

被引：0

作者：

Iavarone, Massimo ^{[1
,2
,3
]}

Invernizzi, Federica ^{[1
,2
,3
]}

Czauderna, Carolin ^{[4
]}

Sanduzzi Zamparelli, Marco ^{[5
]}

Bhoori, Sherrie ^{[6
,7
]}

Amaddeo, Giuliana ^{[8
]}

Manini, Matteo ^{[9
]}

Fraile Lopez, Miguel ^{[10
]}

Anders, Margarita ^{[11
]}

Pinter, Matthias ^{[12
]}

Blanco Rodriguez, Maria Jose ^{[13
]}

Romero Cristobal, Mario ^{[14
]}

Aballay Soteras, Gabriel ^{[15
]}

Pinero, Federico ^{[16
]}

Villadsen, Gerda Elisabeth ^{[17
]}

Weinmann, Arndt ^{[18
]}

Crespo, Gonzalo ^{[19
]}

Mazzaferro, Vincenzo ^{[6
,7
]}

Regnault, Helene ^{[20
]}

De Giorgio, Massimo ^{[9
]}

Gonzalez Dieguez, Maria Luisa ^{[21
]}

Donato, Maria Francesca ^{[1
,2
,3
]}

Varela, Maria ^{[10
]}

Worns, Marcus ^{[4
]}

Lampertico, Pietro ^{[1
,2
,3
]}

Reig, Maria ^{[5
]}

机构：

[1] Univ Milan, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy

[2] Univ Milan, Div Gastroenterol & Hepatol, Milan, Italy

[3] Fdn Irccs Ca Granda Maggiore Hosp, Milan, Italy

[4] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany

[5] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc BCLC Grp, Liver Unit,Idibaps,Ciberehd, Barcelona, Spain

[6] Univ Milan, Liver Surg Transplantat & Gastroenterol, Milan, Italy

[7] Ist Nazl Tumori Fdn Irccs, Milan, Italy

[8] Hop Henri Mondor, Serv Hepatol, Virus Immunite Canc, Equipe 18,Inserm,U955, Creteil, France

[9] Azienda Socio Sanit Terr ASST Papa Giovanni XXIII, Dept Specialty & Transplant Med, Gastroenterol Hepatol & Transplant Unit, Bergamo, Italy

[10] Hosp Univ Cent Asturias, Liver Unit, Oviedo, Spain

[11] Hosp Aleman, Unidad Hepatol & Trasplante Hepat, Buenos Aires, DF, Argentina

[12] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria

[13] Hosp Jerez, Jerez de la Frontera, Spain

[14] Gregorio Maranon Hosp, Liver Dept, Madrid, Spain

[15] Sanat Trinidad Mitre, Buenos Aires, DF, Argentina

[16] Hosp Univ Austral, Buenos Aires, DF, Argentina

[17] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus C, Denmark

[18] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany

[19] Univ Barcelona, Hosp Clin, Liver Transplant Unit, Liver Unit,Idibaps,Ciberehd, Barcelona, Spain

[20] Hop Henri Mondor, Serv Hepatol, Virus Immunite Canc, Equipe 18,Inserm,U955, Creteil, France

[21] Hosp Univ Cent Asturias, Liver Transplant Unit, Buenos Aires, DF, Argentina

来源：

HEPATOLOGY | 2018年 / 68卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB-17

引用

页码：1457A / 1458A

页数：2

共 50 条

[41] Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
Weinmann, Arndt
Niederle, Ina Maria
Koch, Sandra
Hoppe-Lotichius, Maria
Heise, Michael
Dueber, Christoph
Schuchmann, Marcus
Otto, Gerd
Galle, Peter Robert
Woerns, Marcus-Alexander
DIGESTIVE AND LIVER DISEASE, 2012, 44 (05) : 432 - 437
[42] Safety and effectiveness of sorafenib in elderly patients with hepatocellular carcinoma
Kawakam, Takamasa
Mori, Kenichiro
Hiraoka, Atsushi
Aibiki, Toshihiko
Okudaira, Tomonari
Kawamura, Tomoe
Yamago, Hiroka
Tomita, Hideomi
Suga, Yoshifumi
Miyamoto, Yuji
Azemoto, Nobuaki
Miyata, Hideki
Ninomiya, Tomoyuki
Kawasaki, Hideki
Michitaka, Kojiro
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 330 - 330
[43] Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
Kuo, Yuan-Hung
Yen, Yi-Hao
Chen, Yen-Yang
Kee, Kwong-Ming
Hung, Chao-Hung
Lu, Sheng-Nan
Hu, Tsung-Hui
Chen, Chien-Hung
Wang, Jing-Houng
FRONTIERS IN ONCOLOGY, 2021, 11
[44] Natural history and management of recurrent hepatocellular carcinoma after liver transplantation: a multicenter nationwide study
Ningarhari, Massih
Henry, Camille
Boleslawski, Emmanuel
Besch, Camille
Faitot, Francois
Assenat, Eric
Herrero, Astrid
Ursic-Bedoya, Jose
Robin, Fabien
Uguen, Thomas
Antonini, Teresa
Erard, Domitille
Radenne, Sylvie
Brusset, Bleuenn
Decaens, Thomas
Allaire, Manon
Conti, Filomena
Barraud, Helene
Elkrief, Laure
Salame, Ephrem
Boillot, Olivier
Dumortier, Jerome
NtandjaWandji, Line Carolle
Louvet, Alexandre
Mathurin, Philippe
Dharancy, Sebastien
Lassailly, Guillaume
JOURNAL OF HEPATOLOGY, 2023, 78 : S67 - S68
[45] Comparative effectiveness of regorafenib and nivolumab as sequential therapies in patients after sorafenib failure for hepatocellular carcinoma patients: A cohort study in Taiwan
Yeh, Tzuyu
Chang, Kaicheng
Chen, Hui-Yu
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 343 - 344
[46] Outcome of patients with recurrent hepatocellular carcinoma after liver transplantation
Finkenstedt, A.
Graziadei, I. W.
Zoller, H.
Nachbaur, K.
Mark, W.
Vogel, W.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[47] OUTCOME OF PATIENTS WITH RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION
Graziadei, I.
Finkenstedt, A.
Nachbaur, K.
Zoller, H.
Mark, W.
Vogel, W.
JOURNAL OF HEPATOLOGY, 2010, 52 : S91 - S91
[48] Outcome of Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation
Graziadei, Ivo
Finkenstedt, Armin
Nachbaur, Karin
Zoller, Heinz
Mark, Walter
Vogel, Wolfgang
GASTROENTEROLOGY, 2010, 138 (05) : S812 - S812
[49] Outcome of patients with recurrent hepatocellular carcinoma after liver transplantation
Graziadei, I. W.
Millonig, G.
Kern, M.
Mark, W.
Margreiter, R.
Vogel, W.
JOURNAL OF HEPATOLOGY, 2007, 46 : S106 - S106
[50] Radioembolization for recurrent hepatocellular carcinoma after liver transplantation: A multicenter exploratory analysis
Caldwell, Brandon M.
Gabr, Ahmed
Entezari, Pouya
Sher, Alex
Kim, Edward
Johnson, Guy E.
Salem, Riad
Lewandowski, Robert J.
LIVER TRANSPLANTATION, 2023, 29 (02) : 229 - 232

← 1 2 3 4 5 →